78 related articles for article (PubMed ID: 20525452)
1. In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images.
Couto RM; De Barboza MF; De Souza AA; Muramoto E; Mengatti J; De Araújo EB
Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):6-11. PubMed ID: 20525452
[TBL] [Abstract][Full Text] [Related]
2. Preparation and pre-clinical study of 177Lu-labelled hydroxyapatite for application in radiation synovectomy of small joints.
Abbasi I; Ishfaq M; Sohaib M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):458-68. PubMed ID: 21068710
[TBL] [Abstract][Full Text] [Related]
3. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
4. Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route.
Vimalnath KV; Chakraborty S; Rajeswari A; Sarma HD; Nuwad J; Pandey U; Kamaleshwaran K; Shinto A; Dash A
Nucl Med Biol; 2015 May; 42(5):455-464. PubMed ID: 25659856
[TBL] [Abstract][Full Text] [Related]
5. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
6. Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy.
Chinol M; Vallabhajosula S; Goldsmith SJ; Klein MJ; Deutsch KF; Chinen LK; Brodack JW; Deutsch EA; Watson BA; Tofe AJ
J Nucl Med; 1993 Sep; 34(9):1536-42. PubMed ID: 8394883
[TBL] [Abstract][Full Text] [Related]
7. Formulation and
Mercanoglu G; Alcın G; Ozturkmen Y; Cermik T
Curr Radiopharm; 2024; 17(1):68-76. PubMed ID: 37937551
[TBL] [Abstract][Full Text] [Related]
8. 166Ho-labeled hydroxyapatite particles: a possible agent for liver cancer therapy.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Cancer Biother Radiopharm; 2009 Feb; 24(1):7-14. PubMed ID: 19216630
[TBL] [Abstract][Full Text] [Related]
9. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
[TBL] [Abstract][Full Text] [Related]
10. Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy.
Chakraborty S; Vimalnath KV; Rajeswari A; Shinto A; Sarma HD; Kamaleshwaran K; Thirumalaisamy P; Dash A
J Labelled Comp Radiopharm; 2014 Jun; 57(7):453-62. PubMed ID: 24966157
[TBL] [Abstract][Full Text] [Related]
11. Lutetium-177 tin colloid radiosynovectomy in patients with inflammatory knee joint conditions intractable to prevailing therapy.
Jha P; Arora G; Shamim SA; Mukherjee A; Gautam D; Ballal S; Kumar U; Ansari TM; Bal C
Nucl Med Commun; 2018 Sep; 39(9):803-808. PubMed ID: 29994932
[TBL] [Abstract][Full Text] [Related]
12. Formulation and characterization of lutetium-177-labeled stannous (tin) colloid for radiosynovectomy.
Arora G; Singh M; Jha P; Tripathy S; Bal C; Mukherjee A; Shamim SA
Nucl Med Commun; 2017 Jul; 38(7):587-592. PubMed ID: 28538080
[TBL] [Abstract][Full Text] [Related]
13. 90Y-labeled tin fluoride colloid as a promising therapeutic agent: preparation, characterization, and biological study in rats.
Jankovic D; Vranjes-Djuric S; Djokic D; Markovic M; Ajdinovic B; Jaukovic L; Nikolic N
J Pharm Sci; 2012 Jun; 101(6):2194-203. PubMed ID: 22415405
[TBL] [Abstract][Full Text] [Related]
14. Knee radiosynovectomy with
Santos AO; Ricciardi JBS; Pagnano R; Pereira LFM; Sakuma ET; Matsuda MMN; Bernardes ES; Araújo EB; Brunetto SQ; Takahashi MES; Brunetto EM; Zulli R; Ozelo MC; Etchebehere ECSC
Ann Nucl Med; 2021 Feb; 35(2):232-240. PubMed ID: 33389651
[TBL] [Abstract][Full Text] [Related]
15. Bioevaluation of (90)Y-labeled particles in animal model of arthritis.
Pandey U; Bapat K; Sarma HD; Dhami PS; Naik PW; Samuel G; Venkatesh M
Ann Nucl Med; 2009 Jun; 23(4):333-9. PubMed ID: 19437098
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
[TBL] [Abstract][Full Text] [Related]
17. Absorbed dose profiles for (32)P, (90)Y, (188)Re, (177)Lu, (153)Sm and (169)Er: radionuclides used in radiosynoviortheses treatment.
Torres M; Ayra E; Albuerne O; Montano Delgado MA
Rev Esp Med Nucl; 2009; 28(4):188-92. PubMed ID: 19922831
[TBL] [Abstract][Full Text] [Related]
18. 188Re-labeled hydroxyapatite particles for radiation synovectomy.
Kothari K; Suresh S; Sarma HD; Meera V; Pillai MR
Appl Radiat Isot; 2003 Apr; 58(4):463-8. PubMed ID: 12672625
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 90Y phosphate particles as a possible radiation synoviorthesis agent.
Pandey U; Bapat KN; Samuel G; Sarma HD; Chaudhari PR; Dhami PS; Kannan R; Venkatesh M
Nucl Med Commun; 2005 May; 26(5):459-63. PubMed ID: 15838430
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates.
Li WP; Ma DS; Higginbotham C; Hoffman T; Ketring AR; Cutler CS; Jurisson SS
Nucl Med Biol; 2001 Feb; 28(2):145-54. PubMed ID: 11295425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
